Integrated Research Limited Stock Performance
| IREHF Stock | USD 0.21 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Integrated Research are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Integrated Research Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Integrated Research is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 12.1 M | |
| Total Cashflows From Investing Activities | -9.7 M | |
| Free Cash Flow | 5.1 M |
Integrated |
Integrated Research Relative Risk vs. Return Landscape
If you would invest 21.00 in Integrated Research Limited on October 30, 2025 and sell it today you would earn a total of 0.00 from holding Integrated Research Limited or generate 0.0% return on investment over 90 days. Integrated Research Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Integrated, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Integrated Research Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Integrated Research for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Integrated Research can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Integrated Research generated a negative expected return over the last 90 days | |
| Integrated Research has some characteristics of a very speculative penny stock | |
| About 34.0% of the company shares are held by company insiders |
Integrated Research Fundamentals Growth
Integrated Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Integrated Research, and Integrated Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integrated Pink Sheet performance.
| Return On Equity | 0.0181 | |||
| Return On Asset | -0.0351 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 49.44 M | |||
| Shares Outstanding | 172.96 M | |||
| Price To Earning | 12.50 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 0.88 X | |||
| Revenue | 62.87 M | |||
| EBITDA | 10.4 M | |||
| Cash And Equivalents | 14.93 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 11.19 M | |||
| Debt To Equity | 0.13 % | |||
| Book Value Per Share | 0.51 X | |||
| Cash Flow From Operations | 16.94 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 124.44 M | |||
About Integrated Research Performance
By analyzing Integrated Research's fundamental ratios, stakeholders can gain valuable insights into Integrated Research's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Integrated Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Integrated Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company was incorporated in 1988 and is based in North Sydney, Australia. Integrated Research operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 224 people.Things to note about Integrated Research performance evaluation
Checking the ongoing alerts about Integrated Research for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Integrated Research help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integrated Research generated a negative expected return over the last 90 days | |
| Integrated Research has some characteristics of a very speculative penny stock | |
| About 34.0% of the company shares are held by company insiders |
- Analyzing Integrated Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integrated Research's stock is overvalued or undervalued compared to its peers.
- Examining Integrated Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integrated Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integrated Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integrated Research's pink sheet. These opinions can provide insight into Integrated Research's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Integrated Pink Sheet analysis
When running Integrated Research's price analysis, check to measure Integrated Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Research is operating at the current time. Most of Integrated Research's value examination focuses on studying past and present price action to predict the probability of Integrated Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Research's price. Additionally, you may evaluate how the addition of Integrated Research to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges |